Most cases of RTT are caused by de novo loss-of-function mutations in the MECP2 gene that encodes methyl-CpG-binding protein 2 (MeCP2), a DNA-binding protein with roles in epigenetic regulation of gene expression. The gene discussed is MECP2; the disease is Rett syndrome.